Key Market Growth Noninvasive Cancer Diagnostics and Technologies
Non-invasive diagnostic is a process of identifying the disease conditions with minimal incision in body during diagnosis. The Noninvasive Cancer Diagnostics and Technologies Market for diagnostic/in-vitro diagnostics valued at $49.2 billion in 2012, which shows potential for market growth, especially in chronic diseases. Non-invasive cancer diagnostics is gaining importance over conventional diagnosis due to increase in incidences of chronic cancer such as breast cancer, and lung cancer. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed...
View full press release